CoChat

The Pro-inflammatory Effects of Glucocorticoids in the Brain

Open access
Duque, Erica de Almeida, Munhoz, Carolina Demarchi · 2016 · Frontiers in Endocrinology
Cited by 115

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Glucocorticoids are a class of steroid hormones derived from cholesterol. Their actions are mediated by the glucocorticoid and mineralocorticoid receptors, members of the superfamily of nuclear receptors, which, once bound to their ligands, act as transcription factors that can directly modulate gene expression. Through protein-protein interactions with other transcription factors, they can also regulate the activity of many genes in a composite or tethering way. Rapid non-genomic signaling was also demonstrated since glucocorticoids can act through membrane receptors and activate signal transduction pathways, such as protein kinases cascades, to modulate other transcriptions factors and activate or repress various target genes. By all these different mechanisms, glucocorticoids regulate numerous important functions in a large variety of cells, not only in the peripheral organs but also in the central nervous system during development and adulthood. In general, glucocorticoids are considered anti-inflammatory and protective agents due to their ability to inhibit gene expression of pro-inflammatory mediators and other possible damaging molecules. Nonetheless, recent studies have uncovered situations in which these hormones can act as pro-inflammatory agents depending on the dose, chronicity of exposure, and the structure/organ analyzed. In this review, we will provide an overview of the conditions under which these phenomena occur, a discussion that will serve as a basis for exploring the mechanistic foundation of glucocorticoids pro-inflammatory gene regulation in the brain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2016.00078

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 51

  1. Palm, 2009, Pattern recognition receptors and control of adaptive immunity, Immunol Rev, 227, 221, 10.1111/j.1600-065X.2008.00731.x · DOI · Paper page
  2. Akira, 2011, Innate immunity and adjuvants, Philos Trans R Soc Lond B Biol Sci, 366, 2748, 10.1098/rstb.2011.0106 · DOI · Paper page
  3. Medzhitov, 2010, Inflammation 2010: new adventures of an old flame, Cell, 140, 771, 10.1016/j.cell.2010.03.006 · DOI · Paper page
  4. Wensveen, 2015, NK cells link obesity-induced adipose stress to inflammation and insulin resistance, Nat Immunol, 16, 376, 10.1038/ni.3120 · DOI · Paper page
  5. Golia, 2014, Inflammation and cardiovascular disease: from pathogenesis to therapeutic target, Curr Atheroscler Rep, 16, 435, 10.1007/s11883-014-0435-z · DOI · Paper page
  6. Muller-Ladner, 2005, Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis, Nat Clin Pract Rheumatol, 1, 102, 10.1038/ncprheum0047 · DOI · Paper page
  7. Baumgart, 2012, Crohn’s disease, Lancet, 380, 1590, 10.1016/S0140-6736(12)60026-9 · DOI · Paper page
  8. Pedersen, 2014, Inhibitors of apoptosis (IAPs) regulate intestinal immunity and inflammatory bowel disease (IBD) inflammation, Trends Mol Med, 20, 652, 10.1016/j.molmed.2014.09.006 · DOI
  9. Sousa, 2000, Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform, J Allergy Clin Immunol, 105, 943, 10.1067/mai.2000.106486 · DOI · Paper page
  10. Wenzel, 2012, Severe asthma: from characteristics to phenotypes to endotypes, Clin Exp Allergy, 42, 650, 10.1111/j.1365-2222.2011.03929.x · DOI · Paper page
  11. Esser, 2015, Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease, Expert Opin Investig Drugs, 24, 283, 10.1517/13543784.2015.974804 · DOI · Paper page
  12. Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 · DOI · Paper page
  13. Colotta, 2009, Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability, Carcinogenesis, 30, 1073, 10.1093/carcin/bgp127 · DOI · Paper page
  14. Schweingruber, 2012, Mechanisms of glucocorticoids in the control of neuroinflammation, J Neuroendocrinol, 24, 174, 10.1111/j.1365-2826.2011.02161.x · DOI · Paper page
  15. Beato, 2000, Steroid hormone receptors: an update, Hum Reprod Update, 6, 225, 10.1093/humupd/6.3.225 · DOI · Paper page
  16. Sakamoto, 2012, Rapid signaling of steroid hormones in the vertebrate nervous system, Front Biosci (Landmark Ed), 17, 996, 10.2741/3970 · DOI
  17. Ligr, 2012, Mifepristone inhibits GRbeta coupled prostate cancer cell proliferation, J Urol, 188, 981, 10.1016/j.juro.2012.04.102 · DOI
  18. Shahidi, 1999, Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia, Biochem Biophys Res Commun, 254, 559, 10.1006/bbrc.1998.9980 · DOI
  19. Oakley, 2013, The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease, J Allergy Clin Immunol, 132, 1033, 10.1016/j.jaci.2013.09.007 · DOI · Paper page
  20. Carruthers, 2015, Phosphorylation of glucocorticoid receptor tau1c transactivation domain enhances binding to CREB binding protein (CBP) TAZ2, Biochem Biophys Res Commun, 457, 119, 10.1016/j.bbrc.2014.12.021 · DOI
  21. Li, 2011, A retrospective on nuclear receptor regulation of inflammation: lessons from GR and PPARs, PPAR Res, 2011, 742785, 10.1155/2011/742785 · DOI
  22. Falkenstein, 2000, Multiple actions of steroid hormones – a focus on rapid, nongenomic effects, Pharmacol Rev, 52, 513
  23. De Bosscher, 2006, Cross-talk between nuclear receptors and nuclear factor kappaB, Oncogene, 25, 6868, 10.1038/sj.onc.1209935 · DOI · Paper page
  24. Karin, 2001, AP-1 – glucocorticoid receptor crosstalk taken to a higher level, J Endocrinol, 169, 447, 10.1677/joe.0.1690447 · DOI · Paper page
  25. Whitehead, 1997, cAMP response element-binding protein phosphorylation and DNA binding activity are increased in the anterior pituitary gland following glucocorticoid depletion, J Mol Endocrinol, 19, 291, 10.1677/jme.0.0190291 · DOI
  26. Bartholome, 2004, Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis, FASEB J, 18, 70, 10.1096/fj.03-0328com · DOI · Paper page
  27. Boncompagni, 2015, Membrane glucocorticoid receptors are localised in the extracellular matrix and signal through the MAPK pathway in mammalian skeletal muscle fibres, J Physiol, 593, 2679, 10.1113/JP270502 · DOI
  28. Sionov, 2006, Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis, J Exp Med, 203, 189, 10.1084/jem.20050433 · DOI · Paper page
  29. Sundahl, 2015, Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds, Pharmacol Ther, 152, 28, 10.1016/j.pharmthera.2015.05.001 · DOI · Paper page
  30. Smith, 2010, Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes, Prog Brain Res, 182, 1, 10.1016/S0079-6123(10)82001-1 · DOI · Paper page
  31. Sorrells, 2014, Glucocorticoids increase excitotoxic injury and inflammation in the hippocampus of adult male rats, Neuroendocrinology, 100, 129, 10.1159/000367849 · DOI
  32. Lehnardt, 2010, Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury, Glia, 58, 253, 10.1002/glia.20928 · DOI · Paper page
  33. Juedes, 2001, Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis, J Immunol, 166, 5168, 10.4049/jimmunol.166.8.5168 · DOI · Paper page
  34. Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J Immunol, 173, 3916, 10.4049/jimmunol.173.6.3916 · DOI · Paper page
  35. Frank, 2010, Aging sensitizes rapidly isolated hippocampal microglia to LPS ex vivo, J Neuroimmunol, 226, 181, 10.1016/j.jneuroim.2010.05.022 · DOI · Paper page
  36. Chapman, 2010, Synaptic correlates of increased cognitive vulnerability with aging: peripheral immune challenge and aging interact to disrupt theta-burst late-phase long-term potentiation in hippocampal area CA1, J Neurosci, 30, 7598, 10.1523/JNEUROSCI.5172-09.2010 · DOI · Paper page
  37. Hermoso, 2004, Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression, Mol Cell Biol, 24, 4743, 10.1128/MCB.24.11.4743-4756.2004 · DOI · Paper page
  38. Wohleb, 2011, beta-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat, J Neurosci, 31, 6277, 10.1523/JNEUROSCI.0450-11.2011 · DOI · Paper page
  39. Meylan, 2006, Intracellular pattern recognition receptors in the host response, Nature, 442, 39, 10.1038/nature04946 · DOI · Paper page
  40. Man, 2015, Regulation of inflammasome activation, Immunol Rev, 265, 6, 10.1111/imr.12296 · DOI · Paper page
  41. Ding, 2010, Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells, J Pharmacol Exp Ther, 335, 693, 10.1124/jpet.110.171975 · DOI
  42. van Zoelen, 2009, Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo, Shock, 31, 280, 10.1097/SHK.0b013e318186262d · DOI · Paper page
  43. Briet, 2010, Aldosterone: effects on the kidney and cardiovascular system, Nat Rev Nephrol, 6, 261, 10.1038/nrneph.2010.30 · DOI · Paper page
  44. Azibani, 2013, Aldosterone mediates cardiac fibrosis in the setting of hypertension, Curr Hypertens Rep, 15, 395, 10.1007/s11906-013-0354-3 · DOI
  45. Rossignol, 2011, Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (eplerenone post-acute myocardial infarction heart failure efficacy and survival study) substudy, J Am Coll Cardiol, 58, 1958, 10.1016/j.jacc.2011.04.049 · DOI
  46. Herrada, 2010, Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity, J Immunol, 184, 191, 10.4049/jimmunol.0802886jimmunol.0802886 · doi:10.4049/jimmunol.0802886jimmunol.0802886
  47. Usher, 2010, Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice, J Clin Invest, 120, 3350, 10.1172/JCI41080 · DOI · Paper page
  48. Cruz-Topete, 2015, One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids, Neuroimmunomodulation, 22, 20, 10.1159/000362724 · DOI · Paper page
  49. Reul, 2000, The brain mineralocorticoid receptor: greedy for ligand, mysterious in function, Eur J Pharmacol, 405, 235, 10.1016/S0014-2999(00)00677-4 · DOI · Paper page
  50. Frieler, 2011, Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia, Stroke, 42, 179, 10.1161/STROKEAHA.110.598441 · DOI · Paper page
  51. Chantong, 2012, Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells, J Neuroinflammation, 9, 260, 10.1186/1742-2094-9-260 · DOI

Cited by

See all 115

Metadata

Authors
Duque, E. D. A., & Munhoz, C. D.
Venue
Frontiers in Endocrinology
Published
2016-06-28
Volume
7
Pages
78-78
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2468703508
Cited by
115
References
28
FWCI
4.93
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Pro-inflammatory Effects of Glucocorticoids in the Brain. https://app.cochat.ai/papers/10.3389/fendo.2016.00078
The paper
Duque, E. D. A., & Munhoz, C. D. (2016). The Pro-inflammatory Effects of Glucocorticoids in the Brain. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2016.00078

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.